The Company will host a conference call and webcast on March 21, 2024 at 12:30 PM GMT/8:30 AM ET
Oxford, England, March 14, 2024–(BUSINESS WIRE)–Excientia plc (Nasdaq: EXAI) will report its financial results for the fourth quarter and full year ended December 31, 2023 on Thursday, March 21, 2024, before U.S. markets open. I will report to you. The Company will host a conference call and webcast at 12:30 PM GMT / 8:30 AM EDT to provide business updates and review financial results.
A webcast of the live call can be accessed by visiting the Investors and Media section of our website at investors.exscientia.ai. Or dial +1 (888) 596 4144 (US), +44 (800) 358 0970 (UK), +1 (646) 968 2525 (International) and enter Conference ID: 8333895 for a live conference call. You can also access . Replays will be available for 90 days on the Exscientia website under “Events and Presentations'' in the “Investors and Media'' section.
About Excientia
Exscientia is an AI-powered precision medicine company committed to discovering, designing, and developing the best possible medicines in the fastest and most effective way. Exscientia launches the first-ever functional precision oncology platform aimed at guiding treatment selection and improving patient outcomes in prospective interventional clinical studies and bringing AI-designed small molecules to the clinic. Developed. Our internal pipeline is focused on leveraging precision medicine platforms in oncology, and our collaborative pipeline expands our approach to other therapeutic areas. We believe that by pioneering new approaches to drug development, we can quickly turn the best ideas in science into the best medicines for patients. For more information, please visit www.exscientia.ai or follow us on LinkedIn @ex-scientia and X. @exscientiaAI.
View source version on businesswire.com. https://www.businesswire.com/news/home/20240314297594/ja/
contact address
Public relations activities for investors:
Sarah Sherman / Chinedu Okeke
investor@exscientia.ai
media:
Oliver Stallman
media@exscientia.ai
